Context Therapeutics Inc. (CNTX) — Operating Cash Flow
| Fiscal Year | Operating Cash Flow | Change YoY |
|---|---|---|
| 2025 | -$26.39M | -81.3% |
| 2024 | -$14.56M | +30.8% |
| 2023 | -$21.05M | -55.3% |
| 2022 | -$13.55M | -54.0% |
| 2021 | -$8.80M | -750.5% |
| 2020 | -$1.03M | — |
| Fiscal Year | Operating Cash Flow | Change YoY |
|---|---|---|
| 2025 | -$26.39M | -81.3% |
| 2024 | -$14.56M | +30.8% |
| 2023 | -$21.05M | -55.3% |
| 2022 | -$13.55M | -54.0% |
| 2021 | -$8.80M | -750.5% |
| 2020 | -$1.03M | — |